関連する実験動画
Updated: Jun 25, 2026
09:58
A Method for Labeling Vasculature in Embryonic Mice
Published on: October 7, 2011
染色体表皮質由来因子:血管新生の強力な阻害剤
D W Dawson1, O V Volpert, P Gillis
1Department of Microbiology-Immunology, Department of Pathology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, IL 60611, USA.
Science (New York, N.Y.)
|July 10, 1999
まとめ
pigment epithelium-derived factor (PEDF) は,目の血管の成長を阻害する. 減少したPEDFレベルは,網膜症などの状態における新血管化と相関しており,PEDFを潜在的な治療法として示唆しています.
科学分野:
- オフタルモロジック (眼科)
- 血管生物学 血管生物学
- 神経科学は神経科学である.
背景:
- 哺乳類の目の血管系は通常静止状態であり,血管新生阻害剤は角膜とガラス体に血管の成長を防ぐ.
- pigment epithelium-derived factor (PEDF) は,眼血管不全の潜在的役割を持つ既知の神経栄養タンパク質である.
研究 の 目的:
- 角膜とガラスの無血管性を維持する特定の血管新生阻害剤を特定する.
- PEDFの眼球新血管化における役割とその酸素濃度との相関を調査する.
主な方法:
- PEDFを眼球新血管化の主要な阻害剤として特定.
- 異なる酸素濃度で網膜細胞によるPEDF生成の相関分析.
主要な成果:
- 染色体上皮質由来因子 (PEDF) は,角膜とガラスの無血管性を維持する主要な阻害剤として特定されました.
- 網膜細胞によるPEDFの生成は,より高い酸素濃度で増加した.
- 阻害性PEDFの喪失は,不血症による網膜新血管化における許容的役割と関連していた.
結論:
- PEDFは,目の血管不全を維持する上で重要な要因です.
- PEDFのレベルが低下すると,不全性網膜病変の病理的な新血管化に寄与する.
- PEDFは,病理的な新血管化と視力喪失によって特徴づけられる網膜病変の治療に治療的可能性を秘めています.
関連する概念動画
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:07Development of Blood Vessels
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...